Dr. Brooks is Hartnett professor of neurology in the division of neuroscience, faculty of medicine, Imperial College, London. He is also head of the neurology g group at the Medical Research Council Clinical Sciences Centre, Hammersmith Hospital, London. Additionally, he is chief medical officer of Imanet, GE Healthcare PLC. He is a member of the Research Advisory Board of the Michael J. Fox Foundation for Parkinson's Disease Research, the UK Medical Research Council Neuroscience and Mental Health Board, the Research Advisory Panel of the UK Parkinson’s Disease Society (Chairman 1996-7), and UK Huntington’s Disease Association. He was Chairman of the Scientific Issues Committee of the Movement Disorder Society 1998-2002 and of the Council of Management of the UK Parkinson’s Disease Society 1997-8. Dr. Brook’s research involves the use of positron emission tomography and magnetic resonance imaging to diagnose and study the progression of Alzheimers and Parkinsons Disease and their validation of biomarkers therapeutic trials. To date, he has published over 250 reports in peer reviewed journals, including Nature, and his research is currently supported by grants from the UK Medical Research Council, the UK Wellcome Trust, Michael J. Fox Foundation, UK Parkinson’s Disease Society and the pharmaceutical industry.